Clinical Trials Search at Vanderbilt-Ingram Cancer Center

MEASURE: Molecular evaluation of AML patients after stem cell transplant to understand relapse events.

Disease Sites:

Leukemia

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Jayani, Reena

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

01-22-2024

Trial Type:

Basic Science

Protocol ID:

VICCCTT2284

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available